Uses
For the production of mydriasis.
Source: US FDA prescribing information
Fixed-dose combination
Cyclopentolate and Phenylephrine
Also known as cyclopentolate hydrochloride, phenylephrine hydrochloride
Available on request
- Presentations
- 1
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Cyclopentolate and Phenylephrine is a fixed-dose combination medicine. It is available as eye drops for ophthalmic use. MedsAcross supplies Cyclopentolate and Phenylephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Alpha-1 Adrenergic Agonist, Adrenergic alpha1-Agonists
- US FDA first approval
- Approved
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Ophthalmic
- Dosage forms
- Eye drops
- Fixed-dose combination of
- Cyclopentolate, Phenylephrine
- Identifiers
- RxCUI 690312Q48566668
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
Instill one drop in each eye every five to ten minutes. To minimize systemic absorption, apply pressure over the nasolacrimal sac for two to three minutes following instillation. Observe infants closely for at least 30 minutes.
Source: US FDA prescribing information
Contraindications
Do not use in patients with hypersensitivity to any component of this preparation.
Source: US FDA prescribing information
Warnings and precautions
FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION. There have been reports of serious cardiovascular reactions, including ventricular arrhythmias and myocardial infarctions, in patients using higher concentrations of phenylephrine. These episodes, some fatal, have usually occurred in patients with pre-existing cardiovascular diseases. This preparation may cause central nervous system (CNS) disturbances. This is especially true in younger age groups, but may occur at any age, especially with the stronger solutions. Infants are especially prone to CNS and cardiopulmonary side effects from cyclopentolate.
Source: US FDA prescribing information
Side effects
Ocular The following ocular adverse experiences have been associated with the use of CYCLOMYDRIL ® (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution): increased intraocular pressure, burning/irritation upon instillation, photophobia, blurred vision and superficial punctate keratitis. Nonocular Use of cyclopentolate hydrochloride has been associated with psychotic reactions and behavioral disturbances in children. These disturbances include ataxia, incoherent speech, restlessness, hallucinations, hyperactivity, seizures, disorientation as to time and place. This drug produces reactions similar to those of other adrenergic and anticholinergic drugs, however, the central nervous system manifestations as noted above are most common.
Source: US FDA prescribing information
Storage
Store at 8°C to 25°C (46°F - 77°F)
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
1 presentations of Cyclopentolate and Phenylephrine, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Cyclomydril 2 mg/10 mg per mL eye dropsOphthalmic | Cyclopentolate and Phenylephrine | Alcon Laboratories | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Cyclopentolate and Phenylephrine available for export from India?
Yes, on request. MedsAcross lists 1 presentations of Cyclopentolate and Phenylephrine and sources them for licensed hospitals, importers and physicians against valid import documents.
What brand names does Cyclopentolate and Phenylephrine have?
The catalogue lists 1 brand names for Cyclopentolate and Phenylephrine, including Cyclomydril.
Does Cyclopentolate and Phenylephrine need cold chain shipping?
No listed presentation of Cyclopentolate and Phenylephrine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Cyclomydril prescribing information (Alcon Laboratories). U.S. National Library of Medicine, DailyMed. Retrieved 15 May 2025
Request Cyclopentolate and Phenylephrine for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.